Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Barriers and Facilitators to Accessing Huntington’s Disease (HD) Care: HD Providers’ Perspectives

Author:Tobar, Mariann   Perez, Paola   Aradi, Stephen   Duffy, Alexandra   Furr-Stimming, Erin   Moore, Henry   Mendizabal, Adys   

Session Name:P9: Movement Disorders: Care Models and Patient Perceptions in Movement Disorders 2  

Topic:Movement Disorders  

Program Number:P9.006  

Author Institution:UCLA, Los Angeles, CA  UCLA, CA  University of South Florida, Tampa, FL  UC Davis Health, Sacramento, CA  University of Texas Health Science Center-Houston, Houston, TX  University of Miami - Miller School of Medicine, Miami, FL  

Ofatumumab Treatment Up to 8 Years Shows a Favorable and Consistent Safety Profile in People Living With Relapsing Multiple Sclerosis

Author:Pardo, Gabriel   Montalban, Xavier   Cohen, Jeffrey   Morrow, Sarah   Li, Jun   Carr, David   Pearce, Gregory   Solonets, Maria   Abeyewickreme, Anil   de Seze, Jérôme   Nakahara, Jin   Wiendl, Heinz   Hauser, Stephen   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.006  

Author Institution:Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK  Department of Neurology/Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain  Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH  Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada, calgary, AB, Canada  Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland  IQVIA RDS GmbH, Frankfurt, Germany, Germany  Novartis Pharmaceuticals UK Ltd, London, United Kingdom, London, United Kingdom  University Hospital of Strasbourg, Strasbourg, France, Strasbourg, France  Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan  Klinik für Neurologie und Neurophysiologie, Universitätsklinikum Freiburg, Freiburg, Germany, Freiburg im Breisgau, Germany  UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA  

Feasibility of Valve Reprogramming with a Valve-agnostic Cranial Implant in Normal Pressure Hydrocephalus

Author:Bindra, Guneet   Ramireddy, Dhiraj   Lane, Christopher   Duma, Christopher   

Session Name:P9: Aging, Dementia, and Behavioral Neurology: Perspectives in Non-Alzheimer's Disease Diagnostics 6  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P9.006  

Author Institution:California Northstate University College of Medicine, Gold River, CA  California Northstate University College of Medicine, Elk Grove, CA  Hoag Memorial Hospital Presbyterian, NEWPORT BEACH, CA  

Risdiplam as Effective Bridge Therapy Before Gene Replacement in Presymptomatic Infants with SMA

Author:Mazurkiewicz-Beldzinska, Maria   Lemska, Anna   

Session Name:P9: Child Neurology and Developmental Neurology: Neuromuscular Disorders 3  

Topic:Child Neurology and Developmental Neurology  

Program Number:P9.006  

Author Institution:Medical university of Gdansk POLAND, Gdansk, Poland  

Sleep Duration and Risk of Stroke: A Systematic Review of Observational Evidence

Author:Senoga, Joanne   

Session Name:P9: Sleep and Other Neurological Disorders  

Topic:Sleep  

Program Number:P9.006  

Author Institution:Howard University Hospital, Washington, VA